Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricBSXBoston ScientificEWEdwards LifesciencesIDXXIdexx Laboratories
Snapshot
Price$44.72$89.23$523.53
Market cap$67.09B$54.34B$44.00B
Valuation
P/E18.6x46.8x37.7x
Forward P/E13.3x66.9x30x
Growth
Revenue growth17.4%13.8%13.1%
EPS growth74.7%-73.2%25.6%
Profitability
Net margin17.3%17.4%24.6%
ROE14.9%10.6%70.9%
Balance sheet & cash
Debt / equity0.47x0.06x0.53x
Free cash flow yield3.5%2.9%1.9%
Dividend yield———
Verdict
Investment ratingFavorable· 71Neutral· 47Favorable· 69

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBSXtoday $45EWtoday $89IDXXtoday $524
2027$58.60 – $85.95+92% CAGR$68.26 – $100.12+12% CAGR$493.13 – $723.25+38% CAGR
2028$102.39 – $150.17+83% CAGR$69.63 – $102.12+7% CAGR$619.32 – $908.33+32% CAGR
2029$178.89 – $262.37+80% CAGR$71.02 – $104.16+5% CAGR$777.80 – $1,140.77+30% CAGR
2030$312.56 – $458.42+79% CAGR$72.44 – $106.24+4% CAGR$976.84 – $1,432.70+29% CAGR
2031$546.11 – $800.95+78% CAGR$73.89 – $108.37+4% CAGR$1,226.81 – $1,799.32+28% CAGR
5-yr CAGR65.0% – 78.1%-3.7% – 4.0%18.6% – 28.0%